Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metforin
This February 7, 2002 New England Journal of Medicine article, “Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metforin,” explains the findings of a randomized controlled trial testing the efficacy of using medication or lifestyle intervention to prevent or delay the development of diabetes. These findings can help inform diabetes prevention efforts.
With a variety of different primary prevention options and limited available resources, it is important to determine which strategies are most efficacious. This study helps to quantify the preventive benefits of Metforin and lifestyle modification.
Please click here to read the article.